94 related articles for article (PubMed ID: 28737446)
21. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
Gerber JG; Rhodes RJ; Gal J
Chirality; 2004 Jan; 16(1):36-44. PubMed ID: 14628297
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibitory effects of machilin A isolated from Machilus thunbergii on human cytochrome P450 1A and 2B6.
Kim SJ; You J; Choi HG; Kim JA; Jee JG; Lee S
Phytomedicine; 2015 Jun; 22(6):615-20. PubMed ID: 26055126
[TBL] [Abstract][Full Text] [Related]
23. Metabolic Interaction Potential between Clopidogrel and Sulfonylurea Antidiabetic Agents: Effects on Clopidogrel Bioactivation.
Shao H; Lu J; Xu YT; Zhan Y; Chen GM; Zhang HJ
Pharmacology; 2016; 97(1-2):18-24. PubMed ID: 26569597
[TBL] [Abstract][Full Text] [Related]
24. The evaluation of CYP2B6 inhibition by artemisinin antimalarials in recombinant enzymes and human liver microsomes.
Ericsson T; Masimirembwa C; Abelo A; Ashton M
Drug Metab Lett; 2012; 6(4):247-57. PubMed ID: 23506555
[TBL] [Abstract][Full Text] [Related]
25. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.
Chang SY; Chen C; Yang Z; Rodrigues AD
Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) metabolites in human liver microsomes.
Bae SK; Cao S; Seo KA; Kim H; Kim MJ; Shon JH; Liu KH; Zhou HH; Shin JG
Drug Metab Dispos; 2008 Aug; 36(8):1679-88. PubMed ID: 18474675
[TBL] [Abstract][Full Text] [Related]
27. Drug interaction study between bupropion and ticlopidine in male CF-1 mice.
Molnari JC; Hassan HE; Moeller BM; Myers AL
Biol Pharm Bull; 2011; 34(3):447-51. PubMed ID: 21372402
[TBL] [Abstract][Full Text] [Related]
28. Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.
Lee KS; Kim SK
J Appl Toxicol; 2013 Feb; 33(2):100-8. PubMed ID: 21915887
[TBL] [Abstract][Full Text] [Related]
29. Imperatorin is a mechanism-based inactivator of CYP2B6.
Zheng L; Cao J; Lu D; Ji L; Peng Y; Zheng J
Drug Metab Dispos; 2015 Jan; 43(1):82-8. PubMed ID: 25378064
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory Effects of Garcinia cambogia Extract on CYP2B6 Enzyme Activity.
Yu JS; Choi MS; Park JS; Rehman SU; Nakamura K; Yoo HH
Planta Med; 2017 Jul; 83(11):895-900. PubMed ID: 28288493
[TBL] [Abstract][Full Text] [Related]
31. Comparative studies on the cytochrome p450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems.
Salonen JS; Nyman L; Boobis AR; Edwards RJ; Watts P; Lake BG; Price RJ; Renwick AB; Gómez-Lechón MJ; Castell JV; Ingelman-Sundberg M; Hidestrand M; Guillouzo A; Corcos L; Goldfarb PS; Lewis DF; Taavitsainen P; Pelkonen O
Drug Metab Dispos; 2003 Sep; 31(9):1093-102. PubMed ID: 12920164
[TBL] [Abstract][Full Text] [Related]
32. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates.
Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C
Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274
[TBL] [Abstract][Full Text] [Related]
33. Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4'-OH-bupropion in vitro.
Sager JE; Price LS; Isoherranen N
Drug Metab Dispos; 2016 Oct; 44(10):1709-19. PubMed ID: 27495292
[TBL] [Abstract][Full Text] [Related]
34. Psoralen, a mechanism-based inactivator of CYP2B6.
Ji L; Lu D; Cao J; Zheng L; Peng Y; Zheng J
Chem Biol Interact; 2015 Oct; 240():346-52. PubMed ID: 26335194
[TBL] [Abstract][Full Text] [Related]
35. The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico.
Turpeinen M; Raunio H; Pelkonen O
Curr Drug Metab; 2006 Oct; 7(7):705-14. PubMed ID: 17073575
[TBL] [Abstract][Full Text] [Related]
36. Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation.
Turpeinen M; Tolonen A; Uusitalo J; Jalonen J; Pelkonen O; Laine K
Clin Pharmacol Ther; 2005 Jun; 77(6):553-9. PubMed ID: 15961986
[TBL] [Abstract][Full Text] [Related]
37. Effects of suberoylanilide hydroxamic acid on rat cytochrome P450 enzyme activities.
Lin K; Zhang Q; Liu Z; Yang S; Lin Y; Wen C; Zheng Y
Int J Clin Exp Pathol; 2015; 8(5):5584-90. PubMed ID: 26191268
[TBL] [Abstract][Full Text] [Related]
38. Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.
Yanagihara Y; Kariya S; Ohtani M; Uchino K; Aoyama T; Yamamura Y; Iga T
Drug Metab Dispos; 2001 Jun; 29(6):887-90. PubMed ID: 11353758
[TBL] [Abstract][Full Text] [Related]
39. Enantioselective N-demethylation and hydroxylation of sibutramine in human liver microsomes and recombinant cytochrome p-450 isoforms.
Shinde DD; Kim MJ; Jeong ES; Kim YW; Lee JW; Shin JG; Kim DH
J Toxicol Environ Health A; 2014; 77(22-24):1419-30. PubMed ID: 25343291
[TBL] [Abstract][Full Text] [Related]
40. Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients.
Daali Y; Ancrenaz V; Bosilkovska M; Dayer P; Desmeules J
Metabolism; 2011 Nov; 60(11):1584-9. PubMed ID: 21550074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
